Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
276 studies found for:    Shingles
Show Display Options
Rank Status Study
21 Completed Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster Vaccine GSK 1437173A
22 Completed
Has Results
ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)
Conditions: Herpes Zoster;   Shingles
Intervention: Biological: Zoster Vaccine Live
23 Completed
Has Results
Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)
Conditions: Herpes Zoster;   Shingles
Intervention: Biological: Zoster Vaccine Live
24 Completed
Has Results
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Conditions: Herpes Zoster;   HIV Infections
Interventions: Biological: ZOSTAVAX;   Biological: Placebo
25 Completed A Study to Test the Safety and Antibody Response of V212 in Healthy Adults (V212-004)(COMPLETED)
Conditions: Herpes Zoster;   Shingles
Interventions: Biological: Comparator: V212;   Biological: Comparator: Placebo
26 Completed
Has Results
Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles
Conditions: Virus Diseases;   Herpes Zoster
Intervention:
27 Unknown  Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)
Conditions: Herpes Zoster;   Postherpetic Neuralgia
Interventions: Drug: ARYS-01 (sorivudine) cream 3% or placebo cream;   Drug: placebo;   Drug: valaciclovir
28 Active, not recruiting Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster vaccine (GSK 1437173A)
29 Completed Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster
Condition: Herpes Zoster
Intervention: Biological: Herpes Zoster vaccine (GSK1437173A)
30 Recruiting Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster vaccine GSK1437173A;   Biological: Placebo
31 Completed Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine 1437173A;   Biological: Placebo
32 Active, not recruiting A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (Study No. V212-001 AM4)
Condition: Herpes Zoster
Interventions: Biological: V212;   Biological: Matching placebo
33 Completed Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine When Administered Under the Skin (Subcutaneously) vs. Into a Muscle (Intramuscularly) in Adults 50 Years of Age and Older
Condition: Herpes Zoster
Intervention: Biological: Herpes zoster vaccine GSK1437173A
34 Completed
Has Results
Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)
Conditions: Herpes Zoster;   Shingles
Interventions: Biological: Zoster Vaccine, Live (AMP);   Biological: Zoster Vaccine, Live
35 Completed
Has Results
A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)
Condition: Herpes Zoster
Interventions: Biological: ZOSTAVAX™ (concomitant);   Biological: Comparator: Influenza Vaccine;   Biological: ZOSTAVAX™ (Nonconcomitant)
36 Recruiting Herpes Zoster Vaccine for Bone Marrow Transplant Donors
Condition: Herpes Zoster
Intervention: Biological: Zostavax
37 Completed Reduction of Postherpetic Neuralgia in Herpes Zoster
Conditions: Herpes Zoster;   Post-herpetic Neuralgia
Interventions: Drug: Gabapentin;   Drug: Valacyclovir
38 Terminated Study to Find Out if Therapy With the Drug Pregabalin Relieves Pain During Shingles Compared With Placebo
Conditions: Herpes Zoster;   Postherpetic Neuralgia
Intervention: Drug: Pregabalin
39 Completed Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy Subjects
Condition: Herpes Zoster
Intervention: Procedure: Blood sample
40 Recruiting Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy
Condition: Herpes Zoster
Interventions: Biological: GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A);   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years